Cancer Test 2018 Global Industry Key Companies – Abbott , Radient Pharmaceuticals,  BD ,Diagnostics ,Beckman Coulter Market Analysis And Forecast To 2025

Global Cancer Test Market

This report focuses on the global Cancer Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Test development in United States, Europe and China.

Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year. 
According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Therefore, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3339064-global-cancer-test-market-size-status-and-forecast-2018-2025

The key players covered in this study 
Abbott 
Radient Pharmaceuticals 
BD Diagnostics 
Beckman Coulter 
BioCurex 
bioMerieux 
Cepheid 
CytoCore 
DiagnoCure 
Gen-Probe 
Genomic Health 
QIAGEN Marseille (Earlier Ipsogen) 
Myriad Genetics 
Panacea Pharmaceuticals 
Qiagen 
Siemens Heathcare Diagnostics 
Roche 
Ventana Medical Systems 
Trovagene 
Vermillion

During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. 
In 2017, the global Cancer Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

Market segment by Type, the product can be split into 
Laboratory Tests 
Genetic Tests 
Imaging 
Endoscopy

Market segment by Application, split into 
Bladder Cancer Test 
Breast Cancer Test 
Cervical Cancer Test 
Colorectal (Colon) Cancer Test 
Ovarian Cancer Test 
Prostate Cancer Test 
Liver Cancer Test 
Flow Cytometry 
Other Organ Specific Cancer Test

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

The study objectives of this report are: 
To analyze global Cancer Test status, future forecast, growth opportunity, key market and key players. 
To present the Cancer Test development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

Table of Contents-Key Points Covered

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global Cancer Test Market Size Growth Rate by Type (2013-2025) 
1.4.2 Laboratory Tests 
1.4.3 Genetic Tests 
1.4.4 Imaging 
1.4.5 Endoscopy 
1.5 Market by Application 
1.5.1 Global Cancer Test Market Share by Application (2013-2025) 
1.5.2 Bladder Cancer Test 
1.5.3 Breast Cancer Test 
1.5.4 Cervical Cancer Test 
1.5.5 Colorectal (Colon) Cancer Test 
1.5.6 Ovarian Cancer Test 
1.5.7 Prostate Cancer Test 
1.5.8 Liver Cancer Test 
1.5.9 Flow Cytometry 
1.5.10 Other Organ Specific Cancer Test 
1.6 Study Objectives 
1.7 Years Considered

………

12 International Players Profiles 
12.1 Abbott 
12.1.1 Abbott Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Cancer Test Introduction 
12.1.4 Abbott Revenue in Cancer Test Business (2013-2018) 
12.1.5 Abbott Recent Development 
12.2 Radient Pharmaceuticals 
12.2.1 Radient Pharmaceuticals Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Cancer Test Introduction 
12.2.4 Radient Pharmaceuticals Revenue in Cancer Test Business (2013-2018) 
12.2.5 Radient Pharmaceuticals Recent Development 
12.3 BD Diagnostics 
12.3.1 BD Diagnostics Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Cancer Test Introduction 
12.3.4 BD Diagnostics Revenue in Cancer Test Business (2013-2018) 
12.3.5 BD Diagnostics Recent Development 
12.4 Beckman Coulter 
12.4.1 Beckman Coulter Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Cancer Test Introduction 
12.4.4 Beckman Coulter Revenue in Cancer Test Business (2013-2018) 
12.4.5 Beckman Coulter Recent Development 
12.5 BioCurex 
12.5.1 BioCurex Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Cancer Test Introduction 
12.5.4 BioCurex Revenue in Cancer Test Business (2013-2018) 
12.5.5 BioCurex Recent Development 
12.6 bioMerieux 
12.6.1 bioMerieux Company Details 
12.6.2 Company Description and Business Overview 
12.6.3 Cancer Test Introduction 
12.6.4 bioMerieux Revenue in Cancer Test Business (2013-2018) 
12.6.5 bioMerieux Recent Development 
12.7 Cepheid 
12.7.1 Cepheid Company Details 
12.7.2 Company Description and Business Overview 
12.7.3 Cancer Test Introduction 
12.7.4 Cepheid Revenue in Cancer Test Business (2013-2018) 
12.7.5 Cepheid Recent Development 
12.8 CytoCore 
12.8.1 CytoCore Company Details 
12.8.2 Company Description and Business Overview 
12.8.3 Cancer Test Introduction 
12.8.4 CytoCore Revenue in Cancer Test Business (2013-2018) 
12.8.5 CytoCore Recent Development 
12.9 DiagnoCure 
12.9.1 DiagnoCure Company Details 
12.9.2 Company Description and Business Overview 
12.9.3 Cancer Test Introduction 
12.9.4 DiagnoCure Revenue in Cancer Test Business (2013-2018) 
12.9.5 DiagnoCure Recent Development 
12.10 Gen-Probe 
12.10.1 Gen-Probe Company Details 
12.10.2 Company Description and Business Overview 
12.10.3 Cancer Test Introduction 
12.10.4 Gen-Probe Revenue in Cancer Test Business (2013-2018) 
12.10.5 Gen-Probe Recent Development 
12.11 Genomic Health 
12.12 QIAGEN Marseille (Earlier Ipsogen) 
12.13 Myriad Genetics 
12.14 Panacea Pharmaceuticals 
12.15 Qiagen 
12.16 Siemens Heathcare Diagnostics 
12.17 Roche 
12.18 Ventana Medical Systems 
12.19 Trovagene 
12.20 Vermillion

Continued….

Complete Report Details @ https://www.wiseguyreports.com/reports/3339064-global-cancer-test-market-size-status-and-forecast-2018-2025

Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories.

Wise Guy Research Consultants Pvt Ltd
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India

This release was published on openPR.